— Know what they know.
Not Investment Advice

ACLX NASDAQ

Arcellx, Inc.
1W: +0.0% 1M: +0.2% 3M: +68.6% YTD: +81.7% 1Y: +77.8% 3Y: +180.7%
$115.07
Last traded 2026-05-15 — delisted
NASDAQ · Healthcare · Biotechnology · $6.7B mcap · 43M float · 3.37% daily turnover · Short 30% of daily vol

Cash Flow Trends

Operating Cash Flow
-$210M -151.9% ▼
Capital Expenditures
$2M +82.7% ▲
5Y CAGR: +21.2%
Free Cash Flow
-$213M -119.4% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$25M +91.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$65M-$189M-$71M-$107M-$229M
Depreciation & Amort.$1M$1M$2M$5M-$2M
Stock-Based Comp.$7M$22M$42M$61M$78M
Change in Working Capital$3M$4M$225M-$31M-$57M
Other Non-Cash Items$213K$62M$9M-$12M$44K
Operating Cash Flow-$54M-$99M$208M-$83M-$210M
— Investing Activities —
Capital Expenditures-$6M-$2M-$21M-$13M-$2M
Acquisitions (Net)$0$115M$0$0$0
Investment Purchases-$74M-$274M-$442M-$597M-$407M
Investment Sales$0$158M$309M$428M$496M
Other Investing$0-$115M$0$0$0
Investing Cash Flow-$80M-$118M-$155M-$183M$86M
— Financing Activities —
Net Debt Issuance-$387K-$10M-$29M-$40M-$230K
Stock Repurchased-$24K$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$256K$2M$9M$0-$38M
Financing Cash Flow$118M$253M$279M-$24M$99M
Net Change in Cash-$16M$36M$332M-$291M-$25M
Cash End of Period$31M$67M$399M$108M$83M
Free Cash Flow-$60M-$102M$186M-$97M-$213M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms